1 completed, 1 terminated, 1 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
Follow Myocardial Stunning: new trials by email Literature Review of Myocardial Stunning trials Research Report on Myocardial Stunning
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ranolazine a Potential New Therapeutic Application Ranolazine, Placebo - Myocardial Stunning | Phase 4 | Withdrawn | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2019-04-10 | 2021-02-25 | |
| Intracoronary Administration of Levosimendan in Cardiac Surgery Patients levosimendan, Vitamin B 12 - Myocardial Stunning | Phase 4 | Terminated | Tampere University Hospital | 50 | 2018-06-15 | 2019-09-13 |
| The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy) stenting or balloon expansion, aspirin, clopidogrel, ticagrelor, atorvastatin, rosuvastatin, betaloc - Hibernation, Myocardial, Complete Occlusion of Coronary Artery | Phase 4 | Completed | The First Affiliated Hospital of Dalian Medical University | 200 | 2015-09-15 | 2019-03-19 |
Cardiovascular Diseases (1) · Coronary Artery Disease (1)
Heart Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Cardiovascular Diseases (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Coronary Disease (1) · Myocardial Ischemia (1) · Vascular Diseases (1)
Aspirin (1) · Atorvastatin (1) · Clopidogrel (1) · Metoprolol (1) · Percutaneous Coronary Intervention (1) · Ranolazine (1) · Rosuvastatin Calcium (1) · Simendan (1) · Stents (1) · Ticagrelor (1) · Vitamin B 12 (1)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Tampere University Hospital (1) · The First Affiliated Hospital of Dalian Medical University (1)
Finland (1)
Gabriella Arlotta, MD (1) · Panu Virkkala, MD (1) · Rongchong Huang, M.D. (1)